Board Meeting2 Jul 2026, 06:30 pm
Asston Pharma Approves Preferential Issue of ₹27.7 Cr Equity
AI Summary
Asston Pharmaceuticals Ltd's Board of Directors has approved a preferential issue of up to 24,10,431 equity shares at ₹115 per share, aggregating ₹27.72 crore. The shares will be issued to non-promoter category individuals for cash. The company also announced an Extraordinary General Meeting (EGM) on July 31, 2026, to seek shareholder approval for this issuance. The board meeting took place on July 2, 2026, from 3:00 PM to 5:00 PM.
Key Highlights
- Board approves preferential issue of 24.1 lakh equity shares.
- Total issue size aggregates to ₹27.72 crore.
- Shares to be issued to non-promoter category for cash.
- EGM scheduled for July 31, 2026, for shareholder approval.
- Issue price set at ₹115 per equity share.
Price Impact
More from APL